WAVE LIFE SCIENCES LTD. Stock-Based Compensation
WAVE LIFE SCIENCES LTD. (WVE) reported Stock-Based Compensation of $19.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-07-30
- WAVE LIFE SCIENCES LTD. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $10.73M, a 73.22% increase year-over-year.
- WAVE LIFE SCIENCES LTD. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $9.06M, a 82.98% increase year-over-year.
- WAVE LIFE SCIENCES LTD. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $7.35M, a 126.63% increase year-over-year.
- WAVE LIFE SCIENCES LTD. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $6.47M, a 83.29% increase year-over-year.
- WAVE LIFE SCIENCES LTD. share-based payment arrangement, expense for fiscal 2025 was $24.97M, a 90.04% increase from fiscal 2024.
- WAVE LIFE SCIENCES LTD. share-based payment arrangement, expense for fiscal 2024 was $13.14M, a 34.16% increase from fiscal 2023.
- WAVE LIFE SCIENCES LTD. share-based payment arrangement, expense for fiscal 2023 was $9.79M, a 43.03% decline from fiscal 2022.
- WAVE LIFE SCIENCES LTD. share-based payment arrangement, expense for fiscal 2022 was $17.19M, a 4.80% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $19.80M 10-Q · filed 2026-07-30 | $27.15M derived: sum of 3 quarters · filed 2026-07-30 | $33.62M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $9.06M 10-Q · filed 2026-04-28 | $16.41M derived: sum of 2 quarters · filed 2026-04-28 | $22.89M derived: sum of 3 quarters · filed 2026-04-28 | $29.08M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $7.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $13.82M derived: sum of 2 quarters · filed 2026-02-26 | $20.02M derived: sum of 3 quarters · filed 2026-07-30 | $24.97M 10-K · filed 2026-02-26 |
| 2025-09-30 | $6.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $12.67M derived: sum of 2 quarters · filed 2026-07-30 | $17.62M 10-Q · filed 2025-11-10 | $20.86M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $6.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $11.15M 10-Q · filed 2026-07-30 | $14.39M derived: sum of 3 quarters · filed 2026-07-30 | $17.92M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $4.95M 10-Q · filed 2026-04-28 | $8.20M derived: sum of 2 quarters · filed 2026-04-28 | $11.73M derived: sum of 3 quarters · filed 2026-04-28 | $15.21M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $3.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.78M derived: sum of 2 quarters · filed 2026-02-26 | $10.26M derived: sum of 3 quarters · filed 2026-02-26 | $13.14M 10-K · filed 2026-02-26 |
| 2024-09-30 | $3.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $7.02M derived: sum of 2 quarters · filed 2025-11-10 | $9.90M 10-Q · filed 2025-11-10 | $12.25M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $6.37M 10-Q · filed 2025-07-30 | $8.72M derived: sum of 3 quarters · filed 2026-02-26 | $11.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $2.88M 10-Q · filed 2025-05-08 | $5.23M derived: sum of 2 quarters · filed 2026-02-26 | $7.52M derived: sum of 3 quarters · filed 2026-02-26 | $9.93M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.64M derived: sum of 2 quarters · filed 2026-02-26 | $7.04M derived: sum of 3 quarters · filed 2026-02-26 | $9.79M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.69M derived: sum of 2 quarters · filed 2024-11-12 | $7.44M 10-Q · filed 2024-11-12 | $10.35M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | $2.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $5.16M 10-Q · filed 2024-08-08 | $8.07M derived: sum of 3 quarters · filed 2025-03-04 | $11.43M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $2.75M 10-Q · filed 2024-05-10 | $5.66M derived: sum of 2 quarters · filed 2025-03-04 | $9.02M derived: sum of 3 quarters · filed 2025-03-04 | $15.97M derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $6.27M derived: sum of 2 quarters · filed 2025-03-04 | $13.22M derived: sum of 3 quarters · filed 2025-03-04 | $17.19M 10-K · filed 2025-03-04 |
| 2022-09-30 | $3.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $10.32M derived: sum of 2 quarters · filed 2023-11-09 | $14.29M 10-Q · filed 2023-11-09 | $18.01M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $6.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $10.92M 10-Q · filed 2023-08-03 | $14.65M derived: sum of 3 quarters · filed 2023-08-03 | $20.54M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $3.97M 10-Q · filed 2023-05-03 | $7.70M derived: sum of 2 quarters · filed 2023-05-03 | $13.59M derived: sum of 3 quarters · filed 2023-05-03 | $16.32M derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | $3.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $9.62M derived: sum of 2 quarters · filed 2023-03-23 | $12.34M derived: sum of 3 quarters · filed 2023-03-23 | $16.41M 10-K · filed 2023-03-23 |
| 2021-09-30 | $5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $8.62M derived: sum of 2 quarters · filed 2022-11-10 | $12.68M 10-Q · filed 2022-11-10 | $15.90M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $2.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $6.79M 10-Q · filed 2022-08-11 | $10.00M derived: sum of 3 quarters · filed 2022-08-11 | $13.29M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $4.06M 10-Q · filed 2022-05-12 | $7.28M derived: sum of 2 quarters · filed 2022-05-12 | $10.57M derived: sum of 3 quarters · filed 2022-05-12 | $14.36M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $3.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $6.50M derived: sum of 2 quarters · filed 2022-03-03 | $10.30M derived: sum of 3 quarters · filed 2022-03-03 | $14.30M 10-K · filed 2022-03-03 |
| 2020-09-30 | $3.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $7.08M derived: sum of 2 quarters · filed 2021-11-10 | $11.08M 10-Q · filed 2021-11-10 | $16.06M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $3.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $7.79M 10-Q · filed 2021-08-05 | $12.78M derived: sum of 3 quarters · filed 2021-08-05 | $17.80M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $4.00M 10-Q · filed 2021-05-13 | $8.99M derived: sum of 2 quarters · filed 2021-05-13 | $14.01M derived: sum of 3 quarters · filed 2021-05-13 | $19.16M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $10.01M derived: sum of 2 quarters · filed 2021-03-04 | $15.16M derived: sum of 3 quarters · filed 2021-03-04 | $19.51M 10-K · filed 2021-03-04 |
| 2019-09-30 | $5.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $10.18M derived: sum of 2 quarters · filed 2020-11-09 | $14.52M 10-Q · filed 2020-11-09 | $18.53M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $5.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $9.50M 10-Q · filed 2020-08-10 | $13.51M derived: sum of 3 quarters · filed 2020-08-10 | $17.12M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $4.34M 10-Q · filed 2020-05-11 | $8.36M derived: sum of 2 quarters · filed 2020-05-11 | $11.97M derived: sum of 3 quarters · filed 2020-05-11 | $15.51M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $7.62M derived: sum of 2 quarters · filed 2020-03-02 | $11.17M derived: sum of 3 quarters · filed 2020-03-02 | $15.60M 10-K · filed 2020-03-02 |
| 2018-09-30 | $3.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $7.16M derived: sum of 2 quarters · filed 2019-11-05 | $11.59M 10-Q · filed 2019-11-05 | $14.76M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $3.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $7.97M 10-Q · filed 2019-08-06 | $11.15M derived: sum of 3 quarters · filed 2020-03-02 | $14.15M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $4.43M 10-Q · filed 2019-05-10 | $7.61M derived: sum of 2 quarters · filed 2020-03-02 | $10.61M derived: sum of 3 quarters · filed 2020-03-02 | $13.57M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $6.18M derived: sum of 2 quarters · filed 2020-03-02 | $9.14M derived: sum of 3 quarters · filed 2020-03-02 | $12.14M 10-K · filed 2020-03-02 |
| 2017-09-30 | $3.00M 10-Q · filed 2017-11-09 | $5.97M derived: sum of 2 quarters · filed 2017-11-09 | $8.97M 10-Q · filed 2018-11-09 | $11.49M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $2.97M 10-Q · filed 2017-08-09 | $5.97M 10-Q · filed 2018-08-09 | $8.49M derived: sum of 3 quarters · filed 2019-03-01 | $10.68M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $3.00M 10-Q · filed 2018-05-09 | $5.53M derived: sum of 2 quarters · filed 2019-03-01 | $7.71M derived: sum of 3 quarters · filed 2019-03-01 | $8.98M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $4.71M derived: sum of 2 quarters · filed 2019-03-01 | $5.98M derived: sum of 3 quarters · filed 2019-03-01 | $6.85M 10-K · filed 2019-03-01 |
| 2016-09-30 | $2.18M 10-Q · filed 2017-11-09 | $3.45M derived: sum of 2 quarters · filed 2017-11-09 | $4.32M 10-Q · filed 2017-11-09 | $5.13M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $1.27M 10-Q · filed 2017-08-09 | $2.14M 10-Q · filed 2017-08-09 | $2.95M derived: sum of 3 quarters · filed 2018-03-12 | $3.67M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $866.00K 10-Q · filed 2017-05-10 | $1.68M derived: sum of 2 quarters · filed 2018-03-12 | $2.40M derived: sum of 3 quarters · filed 2018-03-12 | $3.04M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $814.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $1.53M derived: sum of 2 quarters · filed 2018-03-12 | $2.18M derived: sum of 3 quarters · filed 2018-03-12 | $4.02M 10-K · filed 2018-03-12 |
| 2015-09-30 | $718.00K 10-Q · filed 2016-11-09 | $1.36M derived: sum of 2 quarters · filed 2016-11-09 | $3.21M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $646.00K 10-Q · filed 2016-08-15 | $2.49M 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | $1.85M 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |